Raligize Uses, Dosage, Side Effects and more
Raligize is under investigation in clinical trial NCT02853604 (Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer).
| Trade Name | Raligize |
| Generic | Axalimogene filolisbac |
| Axalimogene filolisbac Other Names | Adxs hpv, Live, attenuated listeria monocytogenes bacteria, expressing human papilloma virus type 16-e7 tumor antigen, Raligize |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
